Filing Details
Allarity Therapeutics, Inc. (NASDAQ:ALLR) filed a Form 8-K with the Securities and Exchange Commission on July 01, 2026, disclosing a material event.
8k filedNASDAQ:ALLR
Allarity Therapeutics, Inc. (ALLR) Reports Material Event to SEC
Filing Details Allarity Therapeutics, Inc. (NASDAQ:ALLR) filed a Form 8-K with the Securities and Exchange Commission on July 01, 2026, disclosing a material event. Market Context…
Market Context
Allarity Therapeutics, Inc.'s stock currently trades at $1.33 with a market capitalization of $15.6M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Allarity Therapeutics, Inc.'s stock.
All SEC filings for Allarity Therapeutics, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ALLR Stock Page
Frequently Asked Questions
Where can I read ALLR's SEC filings?
Browse all filings on our ALLR SEC filings page.
What types of SEC filings does Allarity Therapeutics, Inc. file?
Public companies like Allarity Therapeutics, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.